Sign In

Mark Kleinman

Senior Project Director at CSL Behring

Professional Background

Mark Kleinman is a consummate professional in the pharmaceutical industry, bringing a wealth of experience in project management and a strong foundation in chemistry. With a Ph.D. in chemistry, he possesses deep expertise in areas such as hematology, cardiovascular health, dermatology, antibacterial therapies, and neuroscience. Currently serving as the Senior Project Director at CSL Behring, Mark has honed his skills in leading complex projects with a focus on drug development and therapeutic strategies. His background in managing teams of scientists and project managers showcases his ability to excel in a fast-paced, high-stakes environment, where strategic decision-making and effective communication are key to success.

Education and Achievements

Mark Kleinman's educational journey has provided him with the critical thinking and analytical skills necessary for a successful career in the pharmaceutical sector. He earned a Ph.D. from the University of Victoria, where he engaged in rigorous research that laid the groundwork for his specialized knowledge in chemistry. Prior to his doctoral studies, he completed his Bachelor of Science (BSc) degree at Concordia University, where he further developed his passion for scientific inquiry and medical applications.

In his role at CSL Behring, Mark has not only led project management but has also contributed to the development of portfolio management strategies and project planning, showcasing his adeptness at navigating the intricacies of pharmaceutical development. His commitment to innovation and high-quality outcomes is evident in his meticulous approach to budget management and risk mitigation, ensuring that projects progress smoothly and efficiently.

Achievements

Mark Kleinman’s career is highlighted by numerous achievements that reflect his dedication to leading successful projects in the pharmaceutical industry. He possesses considerable expertise in developing project plans that align with organizational goals while effectively tracking and reporting on progress. His leadership style is characterized by his ability to motivate and mentor his team, ensuring that his direct reports are not only engaged but also equipped to reach their professional potential.

He is known for his strategic mindset, having built strong relationships with key senior stakeholders that enhance collaboration and support across functions. This networking capability allows Mark to integrate feedback and insights, therefore refining therapeutic strategies and enhancing research outcomes. As a committed leader, he prioritizes the development of his team members, fostering a culture of learning and continuous improvement.

Mark's impact in the pharmaceutical industry is underscored by his initiatives that drive efficiency and innovation. He actively engages in cross-functional collaborations, leveraging insights from multiple therapeutic areas to support the advancement of programs and projects within the organization. His comprehensive understanding of medicine development enables him to contribute effectively to therapeutic area strategy, making him an invaluable asset to CSL Behring.

In conclusion, Mark Kleinman exemplifies excellence in pharmaceutical project management, grounded in his extensive educational background and practical experience. He continues to seek opportunities for growth in leadership, project, and portfolio management, determined to make significant contributions to the industry as he advances his career. His commitment to developing his team and establishing effective strategies ensures that he is well-prepared to tackle the challenges of the ever-evolving pharmaceutical landscape.

Related Questions

How did Mark Kleinman develop his expertise in pharmaceutical project management?
What are some key lessons Mark Kleinman learned from leading teams in drug development?
In what ways does Mark Kleinman foster team collaboration in project management?
What strategies does Mark Kleinman employ for effective budget management in pharmaceutical projects?
How has Mark Kleinman's education contributed to his success at CSL Behring?
Mark Kleinman
Add to my network

Location

Greater Philadelphia